malignant neoplasm without specification of site	is a	cancer
malignant neoplasm without specification of site	is coded as	ICD-10 code C80.1
malignant neoplasm without specification of site	is diagnosed by	biopsy
malignant neoplasm without specification of site	is diagnosed by	histology
malignant neoplasm without specification of site	is treated with	chemotherapy
malignant neoplasm without specification of site	is treated with	radiotherapy
malignant neoplasm without specification of site	is treated with	surgery
malignant neoplasm without specification of site	is managed with	multidisciplinary care
malignant neoplasm without specification of site	may cause	metastasis
malignant neoplasm without specification of site	metastasizes to	liver
malignant neoplasm without specification of site	metastasizes to	bone
malignant neoplasm without specification of site	metastasizes to	brain
malignant neoplasm without specification of site	metastasizes to	lung
malignant neoplasm without specification of site	metastasizes to	lymph node
malignant neoplasm without specification of site	is associated with	paraneoplastic syndrome
malignant neoplasm without specification of site	is associated with	venous thromboembolism
malignant neoplasm without specification of site	is associated with	anemia
malignant neoplasm without specification of site	is associated with	weight loss
malignant neoplasm without specification of site	is associated with	fatigue
malignant neoplasm without specification of site	is associated with	fever
malignant neoplasm without specification of site	is associated with	night sweats
malignant neoplasm without specification of site	is associated with	cachexia
malignant neoplasm without specification of site	increases	mortality
malignant neoplasm without specification of site	increases	readmission
malignant neoplasm without specification of site	increases	length of stay
malignant neoplasm without specification of site	increases	healthcare costs
malignant neoplasm without specification of site	is associated with	cachexia
malignant neoplasm without specification of site	is detected by	biopsy
malignant neoplasm without specification of site	is diagnosed by	biopsy
malignant neoplasm without specification of site	is associated with	elevated tumor markers
tobacco use	is a risk factor for	malignant neoplasm without specification of site
tobacco exposure	is a risk factor for	malignant neoplasm without specification of site
alcohol use	is a risk factor for	malignant neoplasm without specification of site
age	is a risk factor for	malignant neoplasm without specification of site
older age	is associated with	malignant neoplasm without specification of site
family history	is a risk factor for	malignant neoplasm without specification of site
obesity	is a risk factor for	malignant neoplasm without specification of site
sex	is a factor for	malignant neoplasm without specification of site
malignant neoplasm without specification of site	is detected by	imaging
malignant neoplasm without specification of site	is evaluated with	imaging
malignant neoplasm without specification of site	is staged with	imaging
malignant neoplasm without specification of site	presents with	weight loss
malignant neoplasm without specification of site	presents with	fatigue
malignant neoplasm without specification of site	presents with	night sweats
malignant neoplasm without specification of site	presents with	fever
paraneoplastic syndrome	can cause	anemia
paraneoplastic syndrome	can cause	fatigue
bone metastasis	is associated with	malignant neoplasm without specification of site
liver metastasis	is associated with	malignant neoplasm without specification of site
bone metastasis	worsens	prognosis
liver metastasis	worsens	prognosis
bone metastasis	indicates	advanced disease
liver metastasis	indicates	advanced disease
malignant neoplasm without specification of site	has	poor prognosis
malignant neoplasm without specification of site	is managed with	palliative care
malignant neoplasm without specification of site	is monitored by	tumor markers
malignant neoplasm without specification of site	is assessed by	imaging
weight loss	is a symptom of	malignant neoplasm without specification of site
fatigue	is a symptom of	malignant neoplasm without specification of site
fever	is a symptom of	malignant neoplasm without specification of site
night sweats	is a symptom of	malignant neoplasm without specification of site
anemia	is a complication of	malignant neoplasm without specification of site
thrombocytopenia	is a complication of	malignant neoplasm without specification of site
neutropenia	is a complication of	malignant neoplasm without specification of site
palliative therapy	is used for	malignant neoplasm without specification of site
multidisciplinary care	is recommended for	malignant neoplasm without specification of site
biopsy	confirms	malignant neoplasm without specification of site
imaging	is used for	staging malignant neoplasm without specification of site
immunotherapy	is a treatment option for	malignant neoplasm without specification of site
targeted therapy	is a treatment option for	malignant neoplasm without specification of site
chemotherapy	is a treatment option for	malignant neoplasm without specification of site
radiotherapy	is a treatment option for	malignant neoplasm without specification of site
surgery	is a treatment option for	malignant neoplasm without specification of site
ICD-10 code C80.1	corresponds to	malignant neoplasm without specification of site
C80.1	is used for	billing and coding of malignant neoplasm without specification of site
carcinoma	is a type of	malignant neoplasm without specification of site
sarcoma	is a type of	malignant neoplasm without specification of site
lymphoma	is a type of	malignant neoplasm without specification of site
melanoma	is a type of	malignant neoplasm without specification of site
metastasis	indicates	systemic spread of malignant neoplasm without specification of site
lymph node involvement	indicates	advanced disease
bone marrow suppression	can occur with	malignant neoplasm without specification of site
hypercalcemia	can occur with	malignant neoplasm without specification of site
hyponatremia	can occur with	malignant neoplasm without specification of site
electrolyte imbalance	can occur with	malignant neoplasm without specification of site
sepsis	can occur with	advanced malignant neoplasm without specification of site
infection	is a potential complication of	malignant neoplasm without specification of site
anemia	worsens	fatigue
cachexia	is commonly associated with	malignant neoplasm without specification of site
weight loss	correlates with	disease progression in malignant neoplasm without specification of site
mortality risk	is increased by	advanced malignant neoplasm without specification of site
readmission	risk is increased by	malignant neoplasm without specification of site
length of stay	is increased	by malignant neoplasm without specification of site
healthcare costs	are increased	by malignant neoplasm without specification of site
ICU admission	is more likely in	malignant neoplasm without specification of site
palliative care	improves	quality of life in malignant neoplasm without specification of site
end-of-life care	is part of	management of malignant neoplasm without specification of site
survival	is reduced	with malignant neoplasm without specification of site
clinical trial	may include patients with	malignant neoplasm without specification of site
oncology clinic	provides	care for malignant neoplasm without specification of site
